Maha Katabi - Director, 10%+ Owner at Jade Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
JBIO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Maha Katabi since 23 May 2025

Holdings reported by Maha Katabi for Jade Biosciences, Inc.

Form 4 holding Director, 10%+ Owner

Aerovate Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
12,500
Estimated value
$204,625
Report date
05 Jun 2024
Price
$16.37
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transactions reported by Maha Katabi for Jade Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .